| abstract |
The present invention provides the application of MDSCs in the diagnosis and/or typing of aplastic anemia. The present invention finds for the first time that, compared with healthy volunteers, the content of MDSCs in the peripheral blood of AA patients is significantly decreased, and it is significantly correlated with the severity of AA disease. performance, sensitivity and accuracy. The invention provides MDSCs, a diagnostic marker for AA diagnosis and typing, which can diagnose and type AA simply and efficiently, and has the advantages of non-invasiveness, rapidity and easy popularization. |